secwatch.observer — SEC 8-K summary
======================================

Issuer:     Milestone Pharmaceuticals Inc. (MIST)
CIK:        0001408443
Form:       8-K
Filed at:   2026-06-15T20:05:42+00:00
Accession:  0001104659-26-074025
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Milestone Pharma shareholders approve 6.8M share increase to equity plan
------------------------------------------------------------------------

- Shareholders approved 2019 Equity Plan amendment to increase authorized shares by 6,800,000.
- All seven director nominees elected; votes for ranged from 23.4M to 24.2M.
- Ratification of PricewaterhouseCoopers as auditor: 75,025,285 for, 249,836 against.
- Advisory vote on executive compensation passed: 19,665,705 for, 6,990,920 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1408443/000110465926074025/0001104659-26-074025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1408443/000110465926074025/tm2617859d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-074025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer